Related Experiment Video
Updated: May 30, 2026

Real-time Visualization and Analysis of Chondrocyte Injury Due to Mechanical Loading in Fully Intact Murine Cartilage Explants
Published on: January 7, 2019
Proteases involved in cartilage matrix degradation in osteoarthritis
Linda Troeberg1, Hideaki Nagase
1The Kennedy Institute of Rheumatology Division, Imperial College London, London, UK. linda.troeberg@kennedy.ox.ax.uk
Abstract:
Osteoarthritis is a common joint disease for which there are currently no disease-modifying drugs available. Degradation of the cartilage extracellular matrix is a central feature of the disease and is widely thought to be mediated by proteinases that degrade structural components of the matrix, primarily aggrecan and collagen. Studies on transgenic mice have confirmed the central role of Adamalysin with Thrombospondin Motifs 5 (ADAMTS-5) in aggrecan degradation, and the collagenolytic matrix metalloproteinase MMP-13 in collagen degradation. This review discusses recent advances in current understanding of the mechanisms regulating expression of these key enzymes, as well as reviewing the roles of other proteinases in cartilage destruction. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.
Insights
Osteoarthritis involves cartilage matrix degradation by proteinases like ADAMTS-5 and MMP-13. This review explores mechanisms regulating these enzymes and their roles in cartilage destruction.
Area of Science:
- Biochemistry
- Molecular Biology
- Rheumatology
Background:
- Osteoarthritis (OA) is a prevalent joint disease lacking disease-modifying treatments.
- Cartilage extracellular matrix degradation is a hallmark of OA, driven by proteinases.
- Key enzymes implicated are ADAMTS-5 (aggrecan degradation) and MMP-13 (collagen degradation).
Purpose of the Study:
- To review recent advances in understanding the regulatory mechanisms of key proteinases in OA.
- To discuss the roles of other proteinases in cartilage destruction.
- To provide insights into potential therapeutic targets for OA.
Main Methods:
- Review of current scientific literature on osteoarthritis and proteinase function.
- Analysis of studies on transgenic mice models to confirm enzyme roles.
- Synthesis of information on enzyme regulation and cartilage degradation pathways.
Main Results:
- Transgenic mouse studies confirm ADAMTS-5 and MMP-13 are central to aggrecan and collagen degradation, respectively.
- The review highlights recent progress in understanding the expression and regulation of these enzymes.
- Other proteinases contributing to cartilage breakdown are also identified.
Conclusions:
- ADAMTS-5 and MMP-13 are critical targets for understanding and potentially treating osteoarthritis.
- Further research into the regulation of these proteinases may yield novel disease-modifying therapies.
- Understanding the complex interplay of proteinases is crucial for developing effective OA interventions.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Osteoclasts in Bone Remodeling
Matrix Proteoglycans and Glycoproteins
Growth of Cartilage and Bone Tissue
